|
Trial no.:
|
PACTR201810495738292 |
Date of Registration:
|
15/10/2018 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
The Effects of Nigella Sativa on Sickle Cell Disorders |
| Official scientific title |
The Effects of Nigella Sativa on Sickle Cell Disorders among Sudanese Children at Fath Alrahman Albasheer Outpatient Clinic, Khartoum, Sudan 2018-20 |
|
Brief summary describing the background
and objectives of the trial
|
Sickle cell disease is the most Prevalent human hereditary disorder with prominent morbidity and mortality. Nigella Sativa extract is safe, available, cheap, and can be easily administered. The antisickling effect of Nigella sativa on sickle cell disorders was reported but was not studied invivo. Studying the effect of Nigella sativa on the renal system of sicklers is of particular interest because renal impairment impacts the morbidity and mortality. The hematological changes are of special importance because hematological manifestations are central in the pathophysiology of the disease.
The general objective of this study is to investigate the effects of Nigella sativa on patients with sickle cell disease with special emphasis on the renal and hematological systems.
Specific objectives are to investigate the effects of Nigella sativa aqueous extracts on:
i. Hematological parameters in patients with sickle cell disease.
ii. Pulmonary Function patients with sickle cell disease.
iii. Total and fetal hemoglobin concentration in patients with sickle cell disease.
iv. GFR (glomerular filtration rate) in patients with sickle cell disease.
|
| Type of trial |
CCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Haematological Disorders |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Other |
| Anticipated trial start date |
07/11/2018 |
| Actual trial start date |
|
| Anticipated date of last follow up |
27/03/2019 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
40 |
| Actual target sample size (number of participants) |
|
| Recruitment status |
Not yet recruiting |
| Publication URL |
|
|